[Clinical course and prognosis of pleuro-pulmonary metastases in patients after surgery for breast cancer].
The data of 63 female patients suffering from pulmonary and/or pleural metastases of breast cancer are recorded. The patients received chemotherapy, according to the CMF (Cyclosphosphamide-Methotrexate-Fluorouracil) scheme, and in case of appropriate indication, a hormone-therapy as well. The mean survival time of the deceased was 22 months whereas the mean follow-up time of those still living is 61 months. These results are better, than those of the literature, mainly if they are compared to the data of patients with inoperable primary lung cancer.
Böszörményi
K
K
Országos Korányi Tbc és Pulmonológiai Intézet, Budapest, II. Belosztály.
Kanitz
E
E
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D006814:Hungary; D008175:Lung Neoplasms / Q000401:mortality / Q000556:secondary* / Q000628:therapy; D008408:Mastectomy; D008875:Middle Aged; D010997:Pleural Neoplasms / Q000401:mortality / Q000556:secondary* / Q000628:therapy; D015996:Survival Rate
Pleuropulmonalis áttétek klinikai lefolyása és prognózisa emlörák miatt operált betegekben.